These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33782502)

  • 41. Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background.
    Rodrigues M; Echigoya Y; Maruyama R; Lim KR; Fukada SI; Yokota T
    Sci Rep; 2016 Dec; 6():38371. PubMed ID: 27924830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
    Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
    Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
    Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy.
    Catapano F; Scaglioni D; Maresh K; Ala P; Domingos J; Selby V; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Voit T; Verschuuren JJGM; Niks EH; Straub V; Morgan J; Muntoni F
    Epigenomics; 2020 Nov; 12(21):1899-1915. PubMed ID: 33215544
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
    Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
    Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
    Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
    J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
    Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
    J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural disease history of the D2
    van Putten M; Putker K; Overzier M; Adamzek WA; Pasteuning-Vuhman S; Plomp JJ; Aartsma-Rus A
    FASEB J; 2019 Jul; 33(7):8110-8124. PubMed ID: 30933664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PITX2 Enhances the Regenerative Potential of Dystrophic Skeletal Muscle Stem Cells.
    Vallejo D; Hernández-Torres F; Lozano-Velasco E; Rodriguez-Outeiriño L; Carvajal A; Creus C; Franco D; Aránega AE
    Stem Cell Reports; 2018 Apr; 10(4):1398-1411. PubMed ID: 29641992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M; Ehara Y; Li J; Inada K; Ohno K
    Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural history of circulating miRNAs in Duchenne disease: Association with muscle injury and metabolic parameters.
    Almeida-Becerril T; Rodríguez-Cruz M; Hernández-Cruz SY; Ruiz-Cruz ED; Mendoza CRS; Cárdenas-Conejo A; Escobar-Cedillo RE; Ávila-Moreno F; Aquino-Jarquin G
    Acta Neurol Scand; 2022 Nov; 146(5):512-524. PubMed ID: 36000352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Motor performance of young dystrophic mdx mice treated with long-circulating prednisolone liposomes.
    Weller C; Zschüntzsch J; Makosch G; Metselaar JM; Klinker F; Klinge L; Liebetanz D; Schmidt J
    J Neurosci Res; 2012 May; 90(5):1067-77. PubMed ID: 22253213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Van Ry PM; Wuebbles RD; Key M; Burkin DJ
    Mol Ther; 2015 Aug; 23(8):1285-1297. PubMed ID: 26050991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional characteristics of dystrophic skeletal muscle: insights from animal models.
    Watchko JF; O'Day TL; Hoffman EP
    J Appl Physiol (1985); 2002 Aug; 93(2):407-17. PubMed ID: 12133845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
    Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
    Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-431 accelerates muscle regeneration and ameliorates muscular dystrophy by targeting Pax7 in mice.
    Wu R; Li H; Zhai L; Zou X; Meng J; Zhong R; Li C; Wang H; Zhang Y; Zhu D
    Nat Commun; 2015 Jul; 6():7713. PubMed ID: 26151913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy.
    Nitahara-Kasahara Y; Kuraoka M; Guillermo PH; Hayashita-Kinoh H; Maruoka Y; Nakamura-Takahasi A; Kimura K; Takeda S; Okada T
    Stem Cell Res Ther; 2021 Jan; 12(1):78. PubMed ID: 33494794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Social stress is lethal in the mdx model of Duchenne muscular dystrophy.
    Razzoli M; Lindsay A; Law ML; Chamberlain CM; Southern WM; Berg M; Osborn J; Engeland WC; Metzger JM; Ervasti JM; Bartolomucci A
    EBioMedicine; 2020 May; 55():102700. PubMed ID: 32192914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pivotal role of miR-448 in the development of ROS-induced cardiomyopathy.
    Kyrychenko S; Kyrychenko V; Badr MA; Ikeda Y; Sadoshima J; Shirokova N
    Cardiovasc Res; 2015 Dec; 108(3):324-34. PubMed ID: 26503985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy.
    Riuzzi F; Beccafico S; Sagheddu R; Chiappalupi S; Giambanco I; Bereshchenko O; Riccardi C; Sorci G; Donato R
    Sci Rep; 2017 Oct; 7(1):12537. PubMed ID: 28970581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.